STOPDAPT-2 ACS Mortality Prediction Tool

Clinical calculation support · Verify results before clinical use

This page collects selected clinical characteristics for review. The supplied source code used placeholder regression coefficients, and a validated equation for individual 12-month mortality prediction was not provided. For patient safety, this version does not generate a patient-specific mortality percentage.

Clinical profile

Enter the available patient characteristics. All fields are required for profile validation.

Not a validated score
Allowed range: 18–120 years.
Enter the value in mg/dL.
Allowed range: 0–100%.

Clinical context

STOPDAPT-2 ACS was a randomized clinical trial comparing 1–2 months of dual antiplatelet therapy followed by clopidogrel monotherapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome undergoing PCI. It evaluated antithrombotic treatment strategies and clinical outcomes; it should not be treated as a validated individual mortality calculator.

What the source trial reported

The trial's primary endpoint was a composite of cardiovascular outcomes and TIMI major or minor bleeding. The abbreviated DAPT strategy did not meet the prespecified criterion for noninferiority for that composite endpoint. The trial also reported all-cause death as a clinical outcome, but those group-level event rates are not a patient-specific prediction equation.

Variables in this profile

  • Age and serum creatinine.
  • Left ventricular ejection fraction.
  • Killip class.
  • ST-segment deviation on ECG.

The presence of these variables in this form does not mean that they constitute a validated STOPDAPT-2 ACS mortality model.

Reference

Watanabe H, Morimoto T, Natsuaki M, et al.; STOPDAPT-2 ACS Investigators.Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial. JAMA Cardiology. 2022;7(4):407–417.DOI: 10.1001/jamacardio.2021.5244 · PMID: 35234821
Clinical disclaimer: This page is not a validated mortality risk calculator and must not be used to estimate an individual patient's 12-month mortality risk or to direct treatment. Do not use the displayed profile validation as evidence of clinical risk. Use appropriate validated tools, current guidelines, and clinical judgement for patient care.